"The Taliban said that girls should not go to the research centre. I got very depressed," recalls clinical scientist Shekiba Madadi, reflecting on the restrictions placed on women in Afghanistan.
"Even for those who escape, life remains precarious: they worry about the families they left behind, and about their visas expiring. An Afghan passport is like being in prison."
The FDA's decision to decline MDMA as a treatment was unexpected and has raised concerns, especially after Lykos Therapeutics faced backlash over its trial design and ethical issues.
Lykos found their trials under scrutiny, leading to accusations of pressuring participants for positive outcomes while three of their papers were retracted for ethical violations.
[
Collection
]
[
|
...
]